(MC) Moelis - Overview
Sector: Financial Services | Industry: Capital Markets | Exchange: NYSE (USA) | Market Cap: 4.883m USD | Total Return: 21% in 12m
Avg Turnover: 57.9M
Qual. Beats: -1
Rev. Trend: 97.8%
Qual. Beats: 0
Warnings
Choppy
Tailwinds
No distinct edge detected
Moelis & Company (MC) is a global investment bank providing strategic advisory services across five continents. The firm specializes in mergers and acquisitions (M&A), recapitalizations, restructurings, and capital markets transactions for a diverse client base that includes multinational corporations, sovereign wealth funds, and financial sponsors.
As a pure-play advisory firm, Moelis generally avoids balance sheet lending, which reduces credit risk but makes revenue highly dependent on transaction volume and advisory fees. This business model typically results in lower capital requirements compared to diversified bulge-bracket banks. Sector performance is often cyclical, closely following global M&A activity levels and corporate restructuring trends.
To better understand how these advisory cycles impact long-term valuation, you may find it useful to explore the historical data on ValueRay.
- Global M&A activity volume directly dictates advisory fee revenue and stock performance
- Corporate restructuring demand increases during high interest rate environments and economic downturns
- Talent acquisition and retention costs significantly impact operating margins and profitability
- Strategic expansion into private capital advisory diversifies revenue beyond traditional investment banking
| Net Income: 221.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.32 > 0.02 and ΔFCF/TA -2.24 > 1.0 |
| NWC/Revenue: -7.89% < 20% (prev -11.04%; Δ 3.14% < -1%) |
| CFO/TA 0.36 > 3% & CFO 463.0m > Net Income 221.2m |
| Net Debt (114.2m) to EBITDA (300.0m): 0.38 < 3 |
| Current Ratio: 0.70 > 1.5 & < 3 |
| Outstanding Shares: last quarter (79.5m) vs 12m ago 1.17% < -2% |
| Gross Margin: 52.29% > 18% (prev 0.32%; Δ 5.20k% > 0.5%) |
| Asset Turnover: 122.6% > 50% (prev 106.4%; Δ 16.21% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBITDA TTM and Interest Expense TTM) |
| A: -0.09 (Total Current Assets 279.0m - Total Current Liabilities 399.8m) / Total Assets 1.29b |
| B: -0.63 (Retained Earnings -817.3m / Total Assets 1.29b) |
| C: 0.23 (EBIT TTM 287.4m / Avg Total Assets 1.25b) |
| D: -1.23 (Book Value of Equity -823.7m / Total Liabilities 667.0m) |
| Altman-Z'' = -2.43 = D |
| DSRI: 1.13 (Receivables 125.3m/93.3m, Revenue 1.53b/1.28b) |
| GMI: 0.61 (GM 52.29% / 31.66%) |
| AQI: 0.95 (AQ_t 0.54 / AQ_t-1 0.57) |
| SGI: 1.19 (Revenue 1.53b / 1.28b) |
| TATA: -0.19 (NI 221.2m - CFO 463.0m) / TA 1.29b) |
| Beneish M = -3.36 (Cap -4..+1) = AA |
As of May 24, 2026, the stock is trading at USD 65.65 with a total of 761,396 shares traded.
Over the past week, the price has changed by +3.19%,
over one month by -1.11%,
over three months by +9.32% and
over the past year by +20.95%.
Moelis has received a consensus analysts rating of 2.63. Therefore, it is recommended to hold MC.
- StrongBuy: 0
- Buy: 1
- Hold: 5
- Sell: 0
- StrongSell: 2
| Analysts Target Price | 71 | 8.1% |
P/E Forward = 19.4553
P/S = 3.1914
P/B = 9.8077
P/EG = 1.97
Revenue TTM = 1.53b USD
EBIT TTM = 287.4m USD
EBITDA TTM = 300.0m USD
Long Term Debt = unknown (none)
Short Term Debt = 28.9m USD (from shortTermDebt, last fiscal year)
Debt = 267.2m USD (from shortLongTermDebtTotal, last quarter) (leases 267.2m already included)
Net Debt = 114.2m USD (calculated: Debt 267.2m - CCE 152.9m)
Enterprise Value = 5.00b USD (4.88b + Debt 267.2m - CCE 152.9m)
Interest Coverage Ratio = unknown (Ebit TTM 287.4m / Interest Expense TTM 0.0)
EV/FCF = 11.98x (Enterprise Value 5.00b / FCF TTM 417.0m)
FCF Yield = 8.34% (FCF TTM 417.0m / Enterprise Value 5.00b)
FCF Margin = 27.25% (FCF TTM 417.0m / Revenue TTM 1.53b)
Net Margin = 14.46% (Net Income TTM 221.2m / Revenue TTM 1.53b)
Gross Margin = 52.29% ((Revenue TTM 1.53b - Cost of Revenue TTM 730.0m) / Revenue TTM)
Gross Margin QoQ = 34.20% (prev none%)
Tobins Q-Ratio = 3.88 (Enterprise Value 5.00b / Total Assets 1.29b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 267.2m)
Taxrate = 8.38% (3.87m / 46.2m)
NOPAT = 263.3m (EBIT 287.4m * (1 - 8.38%))
Current Ratio = 0.70 (Total Current Assets 279.0m / Total Current Liabilities 399.8m)
Debt / Equity = 0.55 (Debt 267.2m / totalStockholderEquity, last quarter 487.1m)
Debt / EBITDA = 0.38 (Net Debt 114.2m / EBITDA 300.0m)
Debt / FCF = 0.27 (Net Debt 114.2m / FCF TTM 417.0m)
Total Stockholder Equity = 526.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 17.73% (Net Income 221.2m / Total Assets 1.29b)
RoE = 16.46% (Net Income TTM 221.2m / Total Stockholder Equity 1.34b)
RoCE = 32.31% (EBIT 287.4m / Capital Employed (Total Assets 1.29b - Current Liab 399.8m))
RoIC = 34.41% (NOPAT 263.3m / Invested Capital 765.3m)
WACC = 11.60% (E(4.88b)/V(5.15b) * Re(12.24%) + D(267.2m)/V(5.15b) * Rd(0.0%) * (1-Tc(0.08)))
Discount Rate = 12.24% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 95.56 | Cagr: 6.57%
[DCF] Terminal Value 64.92% ; FCFF base≈417.0m ; Y1≈418.6m ; Y5≈443.0m
[DCF] Fair Price = 58.12 (EV 4.44b - Net Debt 114.2m = Equity 4.32b / Shares 74.4m; r=11.60% [WACC]; 5y FCF grow -0.05% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -1.01 | # QB: -1
Revenue Correlation: 97.78 | Revenue CAGR: 31.05% | SUE: -0.09 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.62 | Chg30d=+0.02% | Revisions=-57% | Analysts=11
EPS next Quarter (2026-09-30): EPS=0.77 | Chg30d=+1.59% | Revisions=-57% | Analysts=11
EPS current Year (2026-12-31): EPS=3.09 | Chg30d=+0.54% | Revisions=-73% | GrowthEPS=+3.5% | GrowthRev=+10.2%
EPS next Year (2027-12-31): EPS=3.95 | Chg30d=-2.03% | Revisions=-60% | GrowthEPS=+27.7% | GrowthRev=+19.1%
[Analyst] Revisions Ratio: -73%